ATE25684T1 - Verfahren zur herstellung von biopterin und dessen derivaten. - Google Patents

Verfahren zur herstellung von biopterin und dessen derivaten.

Info

Publication number
ATE25684T1
ATE25684T1 AT82110366T AT82110366T ATE25684T1 AT E25684 T1 ATE25684 T1 AT E25684T1 AT 82110366 T AT82110366 T AT 82110366T AT 82110366 T AT82110366 T AT 82110366T AT E25684 T1 ATE25684 T1 AT E25684T1
Authority
AT
Austria
Prior art keywords
biopterin
diacyl
tetrahydro
prepared
derivatives
Prior art date
Application number
AT82110366T
Other languages
English (en)
Inventor
Max Viscontini
Original Assignee
Kanegafuchi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanegafuchi Chemical Ind filed Critical Kanegafuchi Chemical Ind
Application granted granted Critical
Publication of ATE25684T1 publication Critical patent/ATE25684T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT82110366T 1981-11-13 1982-11-10 Verfahren zur herstellung von biopterin und dessen derivaten. ATE25684T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56182948A JPS5883691A (ja) 1981-11-13 1981-11-13 1′,2′−ジアシル−(6r,s)−5,6,7,8−テトラヒドロ−l−ビオプテリンおよびその製法
EP82110366A EP0079574B1 (de) 1981-11-13 1982-11-10 Verfahren zur Herstellung von Biopterin und dessen Derivaten

Publications (1)

Publication Number Publication Date
ATE25684T1 true ATE25684T1 (de) 1987-03-15

Family

ID=16127151

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82110366T ATE25684T1 (de) 1981-11-13 1982-11-10 Verfahren zur herstellung von biopterin und dessen derivaten.

Country Status (6)

Country Link
US (1) US4540783A (de)
EP (1) EP0079574B1 (de)
JP (1) JPS5883691A (de)
AT (1) ATE25684T1 (de)
CA (1) CA1208218A (de)
DE (1) DE3275546D1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3378634D1 (en) * 1982-09-20 1989-01-12 Wellcome Found Pharmaceutically active pteridine derivatives
GB8318833D0 (en) * 1983-07-12 1983-08-10 Wellcome Found Chemical compounds
JPS5976086A (ja) * 1982-09-20 1984-04-28 ザ ウエルカム フアウンデ−シヨン リミテツド プテリジン化合物
JPS59112987A (ja) * 1982-12-20 1984-06-29 Kanegafuchi Chem Ind Co Ltd 1′,2′―ジアシル―(6r,s)―5,6,7,8―テトラヒドロ―l―ビオプテリンおよびその製法
JPS60178887A (ja) * 1984-02-23 1985-09-12 Kanegafuchi Chem Ind Co Ltd 5,6,7,8−テトラヒドロ−l−ビオプテリンの製造法
JPS60199889A (ja) * 1984-03-24 1985-10-09 Kanegafuchi Chem Ind Co Ltd 5,6,7,8−テトラヒドロ−l−エリスロ−ビオプテリンの硫酸塩およびその製法
US4550109A (en) * 1984-05-31 1985-10-29 The Board Of Regents, The University Of Texas System Lipoidal biopterin compounds
US4665176A (en) * 1984-10-23 1987-05-12 Mitsui Toatsu Chemicals, Incorporated Process for the preparation of 5,6,7,8-tetrahydrofolic acid
US4937342A (en) * 1987-11-30 1990-06-26 Kabushiki Kaisha Vitamin Kenkyusyo Intermediates for synthesizing BH4 and its derivatives
JP2843592B2 (ja) * 1989-02-28 1999-01-06 日清製粉株式会社 L−リボース誘導体
US6162914A (en) * 1998-04-24 2000-12-19 Cerbios-Pharma S.A. Process for the reduction of pterins
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
PL3138566T3 (pl) 2003-11-17 2022-03-07 Biomarin Pharmaceutical Inc. Leczenie fenyloketonurii z użyciem bh4
RU2434870C2 (ru) * 2003-11-17 2011-11-27 Мерк Эпрова Аг Кристаллические формы дигидрохлорида (6r)-l-эритро-тетрагидробиоптерина
AU2012200512C1 (en) * 2003-11-17 2020-04-30 Merck & Cie Crystalline forms of (6R) -L-erythro-tetrahydrobiopterin dihydrochloride
EP2436379A1 (de) 2004-11-17 2012-04-04 BioMarin Pharmaceutical Inc. Stabile Tablettenformulierung
EP1819340A2 (de) * 2004-12-08 2007-08-22 Biomarin Pharmaceutical Inc. Verfahren und zusammensetzungen zur behandlung von lungenhypertonie bei neugeborenen
US7361759B2 (en) 2004-12-27 2008-04-22 Shiratori Pharmaceutical Co., Ltd Method for producing L-biopterin
AU2006321942A1 (en) * 2005-12-05 2007-06-14 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of disease
JP4946391B2 (ja) * 2006-11-28 2012-06-06 ダイキン工業株式会社 熱交換器およびこれを備える空調ユニット
WO2008089148A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Method of treating a metabolic or neuropsychiatry disorder with a bh4 derivative prodrug
CA2675134A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Pterin analogs
PL2139485T3 (pl) 2007-04-11 2013-03-29 Biomarin Pharm Inc Metoda podawania tetrahydrobiopteryny, powiązane kompozycje i sposoby pomiaru
AU2008347005B2 (en) 2008-01-03 2013-10-03 Biomarin Pharmaceutical Inc. Pterin analog for treating BH4 responsive condition
MX2010007452A (es) 2008-01-07 2010-08-18 Biomarin Pharm Inc Metodo para sintetizar tetrahidrobiopterin.
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
WO2019175332A1 (en) 2018-03-14 2019-09-19 Imba - Institut Für Molekulare Biotechnologie Gmbh Bh4 pathway inhibition and use thereof for treating t-cell mediated autoimmune diseases or hypersensitivity
WO2019175328A1 (en) 2018-03-14 2019-09-19 Imba - Institut Für Molekulare Biotechnologie Gmbh Bh4pathwayactivationandusethereoffortreatingcancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500999A (de) * 1967-04-07 1970-12-31 Ciba Geigy Ag Verfahren zur Herstellung von Pterinderivaten
US3505329A (en) * 1968-02-06 1970-04-07 Smithkline Corp Process for the synthesis of biopterin

Also Published As

Publication number Publication date
JPS5883691A (ja) 1983-05-19
CA1208218A (en) 1986-07-22
EP0079574A1 (de) 1983-05-25
DE3275546D1 (en) 1987-04-09
US4540783A (en) 1985-09-10
EP0079574B1 (de) 1987-03-04

Similar Documents

Publication Publication Date Title
ATE25684T1 (de) Verfahren zur herstellung von biopterin und dessen derivaten.
ATE120961T1 (de) Konzentrate von aktiven verbindungen und kombinationen von aktiven verbindungen, ihre verfahren zur herstellung und arzneimittel, die die konzentrate oder die kombinationen enthalten.
ATE15798T1 (de) Heterozyklische carboxamide, zubereitungen, die solche verbindungen enthalten, verfahren zu ihrer herstellung und methoden zur behandlung damit.
DE3483629D1 (de) 2-pyrimidinyl-l-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3684409D1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
DE3877751D1 (de) Kunstlunge vom membrantyp und verfahren zur herstellung.
DE3769174D1 (de) Indolizin-derivate, verfahren zur herstellung und diese enthaltende zusammensetzungen.
ZA934550B (en) Derivatives in the vitamin D series with modifications in 20-position, process for their production,intermediate products for this process,pharmaceutical prepartions containing these derivatives as well as their use for the production of pharmaceutical agents
DE3581566D1 (de) Oxindol-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte.
ATE48417T1 (de) Pyridazin-derivate, wirksam auf das zentralnervensystem, verfahren zur herstellung, und diese enthaltende arzneimittel.
ATE66678T1 (de) Verfahren zur herstellung von makrolidderivaten.
AT338525B (de) Verfahren zur herstellung von copolyamiden enthaltend caprolactam, laurinlactam und 11-aminoundecansaure
DE3382299D1 (de) Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.
HU911140D0 (en) Process for producing cyclo-alkano-(b)-dihydro-indole derivatives and their sulfonamides as well as pharmaceutical preparatives containing said compounds
HU902098D0 (en) Process for producing substituted 1,8-naphthyridine derivatives and pharmaceutical preparatives containing such compounds
DE3787437D1 (de) Sialosylcholesterol, verfahren zu dessen herstellung und arzneimittel zur behandlung von krankheiten des nervensystems.
DE3782207D1 (de) 2-acyloxypropylamin-derivate, verfahren zur herstellung und diese enthaltende arzneimittel.
ATE86619T1 (de) Verfahren zur herstellung von nitroethenderivaten.
ATE173735T1 (de) Thiomarinol-derivate und verfahren zu ihrer herstellung
ATE166642T1 (de) 9-chlor-prostaglandin-ester und -amide und ihre verwendung für die herstellung von arzneimitteln
AT345830B (de) Verfahren zur herstellung von neuen 5:6-benzo- gamma-pyron-derivaten bzw. von pharmazeutisch annehmbaren salzen und von optischen isomeren hievon
DE68918471D1 (de) Milchsäure-Bakterien-Starter für die Futterherstellung und ein diese lebensfähigen Bakterien enthaltendes Mittel.
DE59309380D1 (de) Verfahren zur Herstellung von (6S)-5,6,7,8-Tetrahydrofolsäure
ATE65778T1 (de) 4-oxo-thiazolidin-2-yliden-acetamid-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel zur bekaempfung von erkrankungen des zentralnervensystems.
DE3887212D1 (de) Verfahren zur Herstellung von Derivaten von 6,7-Diazyl-7-desacetylforskolin.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee